mRNA |
tivantinib |
CTRPv2 |
pan-cancer |
AAC |
-0.034 |
0.4 |
mRNA |
tivozanib |
CTRPv2 |
pan-cancer |
AAC |
0.034 |
0.4 |
mRNA |
tivozanib |
GDSC1000 |
pan-cancer |
AAC |
0.016 |
0.6 |
mRNA |
tosedostat |
CTRPv2 |
pan-cancer |
AAC |
0.046 |
0.2 |
mRNA |
tretinoin:carboplatin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.018 |
0.6 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.082 |
0.02 |
mRNA |
triazolothiadiazine |
CTRPv2 |
pan-cancer |
AAC |
-0.014 |
0.7 |
mRNA |
trifluoperazine |
CTRPv2 |
pan-cancer |
AAC |
-0.062 |
0.1 |
mRNA |
triptolide |
CTRPv2 |
pan-cancer |
AAC |
0.0063 |
0.9 |
mRNA |
tubastatin A |
CTRPv2 |
pan-cancer |
AAC |
0.011 |
0.8 |